Stock Scorer

RxSight, Inc. (RXST) · Insider trading

What RxSight's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$117,951
4 insiders, 0% under a plan
Net, 12 months
−$117,951
bought less sold
Latest filing
2026-09-16
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $1.01M bought 2024-11: $1.35M sold 2025-01: $100,014 bought 2025-01: $108,632 sold 2025-01 2025-03: $179,970 sold 2025-07 2026-01 2026-07 2026-09: $117,951 sold
Bought Sold Largest month: $1.35M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Goldshleger IlyaChief Operating Officer – $1.82M 16 2026-09-02 81,509
Corley Jesse AndersonDirector $1.11M – 6 2025-01-16 –
Maniar ShwetaDirector – $282,150 2 2025-01-22 7,383
Fountain TamaraDirector – $179,970 1 2025-03-12 24,793
Wilterding MarkChief Financial Officer – $54,044 1 2026-09-02 25,049
Kurtz Ronald M MDChief Medical Officer – $35,496 1 2026-09-02 71,775
Weinberg EricSee remarks – $14,205 1 2026-09-02 200,348

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-09-02 Weinberg EricSee remarks Sale 2,041 6.96 $14,205 200,348 Form 4
2026-09-02 Goldshleger IlyaChief Operating Officer Sale 2,041 6.96 $14,205 81,509 Form 4
2026-09-02 Wilterding MarkChief Financial Officer Sale 7,765 6.96 $54,044 25,049 Form 4
2026-09-02 Kurtz Ronald M MDChief Medical Officer Sale 5,100 6.96 $35,496 71,775 Form 4
2025-03-12 Fountain TamaraDirector Saleplan 7,000 25.71 $179,970 24,793 Form 4
2025-01-22 Maniar ShwetaDirector Saleplan 3,519 30.87 $108,632 7,383 Form 4
2025-01-16 Corley Jesse AndersonDirector Buyindirect 1,767 31.13 $55,007 3,210 Form 4
2025-01-15 Corley Jesse AndersonDirector Buyindirect 1,443 31.19 $45,007 1,443 Form 4
2024-11-29 Goldshleger IlyaSee remarks Saleplan 3,105 46.08 $143,078 42,246 Form 4
2024-11-26 Goldshleger IlyaSee remarks Saleplan 3,100 45.88 $142,228 42,246 Form 4
2024-11-26 Maniar ShwetaDirector Saleplan 3,782 45.88 $173,518 10,902 Form 4
2024-11-22 Goldshleger IlyaSee remarks Saleplan 3,100 45.00 $139,500 42,246 Form 4
2024-11-18 Goldshleger IlyaSee remarks Saleplan 3,067 45.00 $138,015 42,279 Form 4
2024-11-18 Goldshleger IlyaSee remarks Saleplan 33 45.07 $1,487 42,246 Form 4
2024-11-15 Goldshleger IlyaSee remarks Saleplan 4,875 46.00 $224,250 42,246 Form 4
2024-11-13 Corley Jesse AndersonDirector Buyindirect 5,570 45.00 $250,650 474,141 Form 4
2024-11-13 Corley Jesse AndersonDirector Buy 4,090 44.98 $183,968 36,733 Form 4
2024-11-13 Corley Jesse AndersonDirector Buy 1,705 44.50 $75,872 38,438 Form 4
2024-11-12 Corley Jesse AndersonDirector Buyindirect 11,111 45.37 $504,106 468,571 Form 4
2024-11-12 Goldshleger IlyaSee remarks Saleplan 1,330 46.13 $61,353 42,246 Form 4
2024-11-07 Goldshleger IlyaSee remarks Saleplan 2,900 54.96 $159,384 42,446 Form 4
2024-11-07 Goldshleger IlyaSee remarks Saleplan 200 55.53 $11,106 42,246 Form 4
2024-11-04 Goldshleger IlyaSee remarks Saleplan 2,840 50.98 $144,783 42,506 Form 4
2024-11-04 Goldshleger IlyaSee remarks Saleplan 260 51.74 $13,452 42,246 Form 4
2024-10-30 Goldshleger IlyaSee remarks Saleplan 3,105 51.91 $161,181 42,246 Form 4
2024-10-28 Goldshleger IlyaSee remarks Saleplan 3,100 50.64 $156,984 42,246 Form 4
2024-10-25 Goldshleger IlyaSee remarks Saleplan 3,100 49.79 $154,349 42,246 Form 4
2024-10-22 Goldshleger IlyaSee remarks Saleplan 3,100 49.68 $154,008 42,246 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

24 × option exercise18 × grant or award2 × shares withheld for tax
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-15 Weinberg EricSee remarks Option exercise M +35,168 4.34 235,516 Form 4
2026-08-31 Weinberg EricSee remarks Option exercise M +5,370 – 202,389 Form 4
2026-08-31 Goldshleger IlyaChief Operating Officer Option exercise M +5,370 – 83,550 Form 4
2026-08-31 Wilterding MarkChief Financial Officer Option exercise M +20,441 – 32,814 Form 4
2026-08-31 Kurtz Ronald M MDChief Medical Officer Option exercise M +13,425 – 76,875 Form 4
2026-06-17 Andrews JulieDirector Grant or award A +37,037 – 78,076 Form 4
2026-06-17 Tammenoms Bakker JulietDirector Grant or award A +37,037 – 85,183 Form 4
2026-06-17 Cohen Raymond WDirector Grant or award A +30,864 – 66,532 Form 4
2026-06-17 Corley Jesse AndersonDirector Grant or award A +37,037 – 86,227 Form 4
2026-06-17 Link William J PHDDirector Grant or award A +37,037 – 74,892 Form 4
2026-06-17 Fountain TamaraDirector Grant or award A +37,037 – 72,582 Form 4
2026-06-17 Maniar ShwetaDirector Grant or award A +37,037 – 55,172 Form 4
2026-06-17 Palmisano Robert JDirector Grant or award A +37,037 – 78,076 Form 4
2026-06-17 Warner Robert KeithDirector Grant or award A +37,037 – 78,076 Form 4
2026-04-17 Goldshleger IlyaChief Operating Officer Option exercise M +12,489 4.13 78,180 Form 4
2026-02-28 Gaines ScottChief Customer Officer Option exercise M +6,261 – 17,428 Form 4
2026-02-28 Gaines ScottChief Customer Officer Shares withheld for tax F −2,580 7.61 14,848 Form 4
2026-02-28 Wilterding MarkChief Financial Officer Option exercise M +20,441 – 20,441 Form 4
2026-02-28 Wilterding MarkChief Financial Officer Shares withheld for tax F −8,068 7.61 12,373 Form 4
2025-09-25 Goldshleger IlyaSee remarks Option exercise M +15,096 4.34 57,342 Form 4
2025-09-25 Goldshleger IlyaSee remarks Option exercise M +8,349 4.13 65,691 Form 4
2025-07-31 Cohen Raymond WDirector Grant or award A +35,668 – 35,668 Form 4
2025-06-03 Corley Jesse AndersonDirector Grant or award A +10,752 – 49,190 Form 4
2025-06-03 Tammenoms Bakker JulietDirector Grant or award A +10,752 – 48,146 Form 4
2025-06-03 Andrews JulieDirector Grant or award A +10,752 – 41,039 Form 4
2025-06-03 Palmisano Robert JDirector Grant or award A +10,752 – 41,039 Form 4
2025-06-03 Maniar ShwetaDirector Grant or award A +10,752 – 18,135 Form 4
2025-06-03 Warner Robert KeithDirector Grant or award A +10,752 – 41,039 Form 4
2025-06-03 Fountain TamaraDirector Grant or award A +10,752 – 35,545 Form 4
2025-06-03 Link William J PHDDirector Grant or award A +10,752 – 37,855 Form 4
2025-06-02 Weinberg EricSee remarks Option exercise M +188,002 3.93 195,351 Form 4
2025-04-14 Thunen Shelley BSee remarks Option exercise M +7,792 4.34 38,354 Form 4
2024-11-29 Goldshleger IlyaSee remarks Option exercise M +3,105 15.08 45,351 Form 4
2024-11-26 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4
2024-11-22 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4
2024-11-18 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4
2024-11-15 Goldshleger IlyaSee remarks Option exercise M +4,875 15.08 47,121 Form 4
2024-11-12 Goldshleger IlyaSee remarks Option exercise M +1,330 15.08 43,576 Form 4
2024-11-07 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4
2024-11-04 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4
2024-10-30 Goldshleger IlyaSee remarks Option exercise M +3,105 15.08 45,351 Form 4
2024-10-28 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4
2024-10-25 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4
2024-10-22 Goldshleger IlyaSee remarks Option exercise M +3,100 15.08 45,346 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

RxSight's scores and multiples ›